Cisplatin (80 mg/m2)

DRUG3 trials

Sponsors

Sun Yat-sen University, Fudan University

Conditions

HPV-unrelated Head and Neck Squamous Cell CarcinomaNasopharyngeal Cancinoma (NPC)Nasopharyngeal Carcinoma

Phase 2

Induction PD-1 Inhibitor and Chemotherapy Followed by Chemoradiotherapy in Unresectable or Inoperable HPV-negative LA-HNSCC

Not yet recruitingNCT07776340

Fudan UniversityHPV-unrelated Head and Neck Squamous Cell Carcinoma

Start: 2026-09-01End: 2030-03-01Target: 104Updated: 2026-08-20

Risk-Adapted Anlotinib and PD-L1 for Locoregionally Advanced Nasopharyngeal Carcinoma

Not yet recruitingNCT07904819

Sun Yat-sen UniversityNasopharyngeal Cancinoma (NPC)

Start: 2026-12-01End: 2033-12-31Target: 214Updated: 2026-10-29

Phase 3

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

RecruitingNCT06239727

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2024-03-01End: 2030-02-20Target: 593Updated: 2026-03-06